Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
One of the largest radiopharma companies in the world is acquiring global rights to a pair of novel therapeutic and diagnostic drugs used to target a peptide receptor overexpressed in prostate and breast cancers.
"This article will serve as a landmark reference for navigating short-term labor challenges in radiology," explains one editorial about the suggestions.
Konica Minolta Healthcare Americas, Inc. announced today that the company’s revolutionary Dynamic Digital Radiography (DDR) technology, enabling the visualization of anatomy in motion, will be available on the mKDR Xpress™ Mobile X-ray System.
Two dozen academic physicians from around the U.S. with expertise in point-of-care ultrasound—and no vested interest in POCUS industry players—recently tested and compared four commercially available POCUS handhelds.
The FDA has greenlit a whole-body MRI machine that uses deep learning and advanced image processing to wring “elevated image quality” from a magnet with only 0.55 Tesla field strength.
Fewer than 40% of rural counties in the U.S. can offer residents any access to point-of-care ultrasound, while nearly 90% of their metropolitan counterparts have POCUS aplenty.
A clinical trial pitting MRI against a burgeoning PET/CT technique has found the de facto defending champion better at revealing the presence of any grade of prostate cancer.
Two emerging MRI techniques show promise as all-in-one imaging tests for patients with pain in and below the lower back due to changes in the sacroiliac joint.
Prior to the final proposal’s release, the American College of Radiology reached out to CMS to offer its recommendations on payment rates for five out of the six the new codes.